placebo response in rheumatoid arthritis clinical trials
Published 4 years ago • 311 plays • Length 7:06Download video MP4
Download video MP3
Similar videos
-
5:38
baricitinib versus placebo or adalimumab on patient-reported outcomes in rheumatoid arthritis
-
6:44
video abstract: impact of tofacitinib on components of the acr response criteria
-
29:07
effect of interleukin-6 receptor blockade on surrogates of vascular risk in ra
-
59:57
what clinical trials do not teach us: how to achieve remission in rheumatoid arthritis
-
8:40
the impact of biologic therapy on rheumatoid arthritis
-
57:28
biologics across immune mediated inflammatory disease from the rheumatology perspective
-
12:28
rheumatoid arthritis - causes, symptoms, diagnosis, treatment, pathology
-
11:03
clinical trials & the placebo response - pt 1
-
27:17
rheumatoid arthritis
-
19:12
biologics in ra and other rheumatic diseases
-
3:10
what is a “placebo” in a clinical trial and is it always used?
-
32:50
advances in rheumatoid arthritis
-
32:16
recent advances in the management of rheumatoid arthritis
-
28:29
addressing unmet needs in ra: a physician-patient discussion
-
25:12
sustained remission with etanercept tapering in early rheumatoid arthritis
-
2:27
placebo in clinical trial
-
52:27
3/2/2018: fibromyalgia: it's not an easy visit
-
40:21
overcoming challenges in the management of refractory rheumatoid arthritis
-
41:39
addressing the burden of polyarticular juvenile idiopathic arthritis